TY  - GEN
AU  - Talamillo, A
AU  - Grande, L
AU  - Ruiz-Ontañon, P
AU  - Velasquez, C
AU  - Mollinedo, P
AU  - Torices, S
AU  - Sánchez-Gómez, Pilar
AU  - Aznar, A
AU  - Esparis-Ogando, A
AU  - Lopez-Lopez, C
AU  - Lafita, C
AU  - Berciano, M T
AU  - Montero, J A
AU  - Vazquez-Barquero, A
AU  - Segura, V
AU  - Villagra, N T
AU  - Pandiella, A
AU  - Lafarga, Miguel
AU  - Leon, J
AU  - Martinez-Climent, J A
AU  - Sanz-Moreno, V
AU  - Fernandez-Luna, J L
PY  - 2016
DO  - 10.1038/onc.2016.341
SN  - 0950-9232
UR  - http://hdl.handle.net/20.500.12105/7897
AB  - Long-term survival remains low for most patients with glioblastoma (GBM), which reveals the need for markers of disease outcome and novel therapeutic targets. We describe that ODZ1 (also known as TENM1), a type II transmembrane protein involved in...
LA  - eng
PB  - Springer
KW  - Animals
KW  - Cell Line, Tumor
KW  - Disease Models, Animal
KW  - Gene Knockout Techniques
KW  - Glioblastoma
KW  - Heterografts
KW  - Humans
KW  - Mice
KW  - Neoplastic Stem Cells
KW  - Nerve Tissue Proteins
KW  - Prognosis
KW  - Protein Transport
KW  - Proteolysis
KW  - Proto-Oncogene Proteins c-myc
KW  - Signal Transduction
KW  - Tenascin
KW  - Up-Regulation
KW  - rho-Associated Kinases
KW  - rhoA GTP-Binding Protein
KW  - Gene Expression Regulation, Neoplastic
KW  - Transcription, Genetic
TI  - ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA
TY  - preprint
ER  -